Health & Wellness Today New York
SEE OTHER BRANDS

Get your fresh news on health and wellness in New York

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on April 28, 2025

Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update

Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update

- FHD-909 (LY4050784) advancing in Phase 1 trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population - Preclinical synergistic anti-tumor activity of FHD-909 in combination with pembrolizumab and KRAS …

LifeMD to Report First Quarter 2025 Financial Results on May 6

LifeMD to Report First Quarter 2025 Financial Results on May 6

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three months ended March 31, 2025 after the close of the U.S. financial …

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

SINGAPORE, April 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or the “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel …

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting

Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting

BRISBANE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that a presentation …

Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change

Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change

WINNIPEG, Manitoba, April 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announced its fourth quarter and full year 2024 financial results. Fourth Quarter 2024 Financial Highlights ( …

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025

Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025

BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced multiple presentations …

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call

ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will …

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer

CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial …

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced new preclinical data in collaboration with Moderna on an mRNA …

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET. Cronos will be conducting the meeting in a …

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

Nurix’s DEL-AI platform uses a first-in-class DEL Foundation Model trained on the Company’s proprietary DNA encoded library data Nurix’s DEL Foundation Model can accurately predict novel binders to therapeutically relevant targets, including many targets …

Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025

Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025

Sustained reactivation of mutant p53 drives durable anti-tumor activity across models, including KRAS co-mutant tumors FMC-220 selectively stabilizes p53 Y220C at lower doses, overcoming key limitations of non-covalent approaches Addresses a defined …

Helping Kids Brush Their Teeth: HelloNation Spotlights Dr. Andrew Beuttenmuller of Watertown Pediatric Dentistry And How He Gets Kids Excited About Oral Health

Helping Kids Brush Their Teeth: HelloNation Spotlights Dr. Andrew Beuttenmuller of Watertown Pediatric Dentistry And How He Gets Kids Excited About Oral Health

WATERTOWN, N.Y., April 28, 2025 (GLOBE NEWSWIRE) -- Making dental hygiene fun is a crucial step in helping children build positive associations with oral care. This is a perspective emphasized by Dr. Andrew Beuttenmuller of Watertown Pediatric Dentistry, …

Supra Keto ACV Gummies: Best Gummies for Weight Loss 2025 - (Keto BHB + Keto Plus)

Supra Keto ACV Gummies: Best Gummies for Weight Loss 2025 - (Keto BHB + Keto Plus)

New York, April 28, 2025 (GLOBE NEWSWIRE) -- Within the weight loss supplement industry, Supra Keto BHB + ACV Gummies are revolutionary, employing two of the best fat-burning compounds: Beta-Hydroxybutyrate (BHB) and Apple Cider Vinegar (ACV). The goal of …

Best Testosterone Boosters for Muscle Gain: Top Rated Testosterone Pills for Bodybuilding & Muscle Growth From TestoPrime

Best Testosterone Boosters for Muscle Gain: Top Rated Testosterone Pills for Bodybuilding & Muscle Growth From TestoPrime

Glasgow, United Kingdom, April 28, 2025 (GLOBE NEWSWIRE) -- Testosterone levels are the driving force behind a man’s strength, muscle growth, energy, and overall vitality. But unfortunately, testosterone production naturally peaks during young adulthood— …

Sugar Defender Reviews [Blood Sugar Control Supplement 2025] User Complaints, Ingredients and Possible Side Effects?

Sugar Defender Reviews [Blood Sugar Control Supplement 2025] User Complaints, Ingredients and Possible Side Effects?

Albany, New York, April 28, 2025 (GLOBE NEWSWIRE) -- Sugar Defender's Secret Formula Finally Revealed – Know How It Supports Healthy Blood Sugar Naturally? With our increasingly busy world, it has never been more important to balance blood sugar. Blood …

Milestone Consensus Statement  on AI Issued by Power Users  As Part of the Health IT End-Users Alliance

Milestone Consensus Statement on AI Issued by Power Users As Part of the Health IT End-Users Alliance

Chicago, April 28, 2025 (GLOBE NEWSWIRE) -- Since taking office in January, the Trump-Vance Administration has signaled a new government approach to artificial intelligence (AI), emphasizing a “forward leaning” and “pro innovation” approach to the …

New Study Reveals Homeless Sex Offender Crisis State by State

New Study Reveals Homeless Sex Offender Crisis State by State

Austin, TX, April 28, 2025 (GLOBE NEWSWIRE) -- A new report from the Cicero Institute finds that sex offenders make up a significant proportion of the unsheltered homeless population across many U.S. states. In eight states, over half of the unsheltered …

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

Relmada Therapeutics Presents Positive Initial Phase 2 NDV-01 Data at AUA2025

90% of patients achieved high grade disease-free status at any time point with NDV-01, demonstrating strong proof-of-concept for sustained-release “GEM/DOCE” formulation* NDV-01 showed promising clinical activity in BCG-naïve and BCG-unresponsive patients, …

SARMs Cardarine GW 50156: Cardarine For Sale, Cardarine Cycle, Cardarine Benefits, Cardarine Dosage, Cardarine Before and After, Cardarine Effects, Cardarine Side Effects, Buy, (C-Dine By CrazyBulk)

SARMs Cardarine GW 50156: Cardarine For Sale, Cardarine Cycle, Cardarine Benefits, Cardarine Dosage, Cardarine Before and After, Cardarine Effects, Cardarine Side Effects, Buy, (C-Dine By CrazyBulk)

New York City, April 28, 2025 (GLOBE NEWSWIRE) -- “C-DINE 501516 is an all natural, safe, and legal CARDARINE GW501516 alternative that delivers natural ingredients to help fire-up your metabolism and transition your body into a natural fat-burning state!” …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service